#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Regis Vilchez Email
SVP Finance & Operations . BiomX
How to contact Regis Vilchez
Join and see Regis's contact info for free!Current Roles
Employees:
100Revenue:
$15.5MAbout
BiomX is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. We discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. The Company?s platforms use computational and synthetic biology and cutting-edge research from Profs. Rotem Sorek, Ph.D., Eran Elinav, M.D., Ph.D., and Eran Segal, Ph.D., of The Weizmann Institute of Science; and Professor Timothy K. Lu, M.D., Ph.D., of The Massachusetts Institute of Technology. Investors in the Company include OrbiMed Israel Incubator LP, Johnson & Johnson Development Corporation Inc., Takeda Ventures, Inc., Seventure Partners, Mirae Asset Global Investments, and SBI.BiomX Address
36 E Industrial Rdnull, null
Israel